0000000000724472

AUTHOR

H. Castro

showing 2 related works from this author

P-26 RATIONALE 305: Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line therapy in patients with gastric or gastroesophagea…

2020

Chemotherapymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentHematologyGastroesophageal Junction AdenocarcinomaPlaceboGastroenterologyFirst line therapyOncologyInternal medicinemedicineIn patientbusinessAnnals of Oncology
researchProduct

Advances in Technology for High-Energy Subnuclear Physics. Contribution of the LAA Project.

1990

PhysicsHigh energy[PHYS.HEXP] Physics [physics]/High Energy Physics - Experiment [hep-ex]010308 nuclear & particles physics0103 physical sciences[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]General Physics and Astronomy010306 general physics01 natural sciencesEngineering physics
researchProduct